Y
Yang Zhou
Researcher at Nanchang University
Publications - 43
Citations - 776
Yang Zhou is an academic researcher from Nanchang University. The author has contributed to research in topics: Fatty acid synthase & Osteosarcoma. The author has an hindex of 15, co-authored 38 publications receiving 591 citations.
Papers
More filters
Journal ArticleDOI
Risk Factors for Surgical Site Infection After Posterior Lumbar Spinal Surgery
Jia-Ming Liu,Hui-Lin Deng,Xuan-Yin Chen,Yang Zhou,Dong Yang,Man-Sheng Duan,Shan-Hu Huang,Zhi-Li Liu +7 more
TL;DR: Previous reported risk factors for SSI were confirmed in this study while some new independent risk factors were identified significantly associated with SSI following lumbar spinal surgery, including preoperative low serum level of calcium, decreased preoperative and postoperative albumin, and decreased postoperative hemoglobin.
Journal ArticleDOI
Tumor suppressive microRNA‑424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase
TL;DR: It is suggested that miR-424 plays a key role in inhibiting OS cell migration and invasion through targeting FASN.
Journal ArticleDOI
Is Urgent Decompression Superior to Delayed Surgery for Traumatic Spinal Cord Injury? A Meta-Analysis.
TL;DR: It is suggested that urgent decompression within 24 hours is superior to delayed surgery for SCI, and neurologic outcomes of SCI in patients who underwent early surgery are better than those who underwent late surgery.
Journal ArticleDOI
The risk factors of bone metastases in patients with lung cancer
TL;DR: The incidence of bone metastasis in lung cancer patients was relative high, and physicians should pay attention to the histopathologic type, the serum CA-125 and ALP concentrations when patients were firstly diagnosed with lung cancer for early detecting bone metastases.
Journal ArticleDOI
Clinical characteristics and risk factors for developing bone metastases in patients with breast cancer.
TL;DR: Combined axillary lymph node metastases, high CA153 and ALP, with low hemoglobin with hemoglobin have the highest predictive accuracy for bone metastases in breast cancer.